The nuclear signaling of NF-κB: Current knowledge, new insights, and future perspectives

Cell Research

Volumn 20, Issue 1, 2010, Pages 24-33

  Wan, Fengyi ^a   Lenardo, Michael J ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

DNA binding; Immunity; RPS3

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN SUBUNIT; RIBOSOME PROTEIN; RPS3A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL; CELL NUCLEUS; GENETICS; HUMAN; IMMUNITY; IMMUNOLOGY; INFLAMMATION; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ANIMALS; CELL NUCLEUS; HUMANS; IMMUNITY; INFLAMMATION; NF-KAPPA B; NUCLEAR PROTEINS; PROTEIN SUBUNITS; RIBOSOMAL PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 73849095427     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2009.137     Document Type: Review

References (68)

1. Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappa B by a posttranslational mechanism. Cell 1986; 47:921-928.
2. Lenardo M, Pierce JW, Baltimore D. Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science 1987; 236:1573-1577.
3. Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989; 58:227-229.
4. Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18:2195-2224.
5. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008; 132:344-362.
6. Vallabhapurapu S, Karin M. Regulation and function of NFkappaB transcription factors in the immune system. Annu Rev Immunol 2009; 27:693-733.
7. + T lymphocytes. Science 1992; 256:1452-1456.
8. Su H, Bidere N, Zheng L, et al.. Requirement for caspase-8 in NF-kappaB activation by antigen receptor. Science 2005; 307:1465-1468.
9. Bidere N, Ngo VN, Lee J, et al.. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature 2009; 458:92-96.
10. Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993; 143:1-62.
11. Chen LF, Greene WC. Shaping the nuclear action of NFkappaB. Nat Rev Mol Cell Biol 2004; 5:392-401.
12. Rothwarf DM, Karin M. The NF-kappaB activation pathway: a paradigm in information transfer from membrane to nucleus. Sci STKE 1999; 1999:RE1.
13. Wan F, Anderson DE, Barnitz RA, et al.. Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. Cell 2007; 131:927-939.
14. Urban MB, Schreck R, Baeuerle PA. NF-kappaB contacts DNA by a heterodimer of the p50 and p65 subunit. EMBO J 1991; 10:1817-1825.
15. Phelps CB, Sengchanthalangsy LL, Malek S, Ghosh G. Mechanism of kappaB DNA binding by Rel/NF-kappaB dimers. J Biol Chem 2000; 275:24392-24399. (Pubitemid 30626529)
16. Wan F, Lenardo MJ. Specification of DNA binding activity of NF-kappaB proteins. Cold Spring Harb Perspect Biol 2009; 1:a000067.
17. Lenardo MJ, Fan CM, Maniatis T, Baltimore D. The involvement of NF-kappaB in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 1989; 57:287-294.
18. Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005; 7:758-765.
19. Courtois G, Israel A. NF-kappaB defects in humans: the NEMO/incontinentia pigmenti connection. Sci STKE 2000; 2000:PE1.
20. Scheidereit C. IkappaB kinase complexes: gateways to NFkappaB activation and transcription. Oncogene 2006; 25:6685-6705.
21. Hacker H, Karin M. Regulation and function of IKK and IKKrelated kinases. Sci STKE 2006; 2006:re13.
22. Chen FE, Huang DB, Chen YQ, Ghosh G. Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 1998; 391:410-413.
23. Natoli G, Saccani S, Bosisio D, Marazzi I. Interactions of NFkappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 2005; 6:439-445.
24. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 2006; 25:6706-6716.
25. Sun SC, Ley SC. New insights into NF-kappaB regulation and function. Trends Immunol 2008; 29:469-478.
26. Mankan AK, Lawless MW, Gray SG, Kelleher D, McManus R. NF-kappaB regulation: the nuclear response. J Cell Mol Med 2009; 13:631-643.
27. Hoffmann A, Leung TH, Baltimore D. Genetic analysis of NFkappaB/ Rel transcription factors defines functional specificities. EMBO J 2003; 22:5530-5539.
28. Leung TH, Hoffmann A, Baltimore D. One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimers. Cell 2004; 118:453-464.
29. Martone R, Euskirchen G, Bertone P, et al.. Distribution of NFkappaB- binding sites across human chromosome 22. Proc Natl Acad Sci USA 2003; 100:12247-12252.
30. Schreiber J, Jenner RG, Murray HL, et al.. Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. Proc Natl Acad Sci USA 2006; 103:5899-5904.
31. Lim CA, Yao F, Wong JJ, et al.. Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell 2007; 27:622-635.
32. Siomi H, Matunis MJ, Michael WM, Dreyfuss G. The premRNA binding K protein contains a novel evolutionarily conserved motif. Nucleic Acids Res 1993; 21:1193-1198.
33. Cadera EJ, Wan F, Amin RH, et al.. NF-kappaB activity marks cells engaged in receptor editing. J Exp Med 2009; 206: 1803-1816.
34. Kwon O, Kim KA, He L, et al.. Complex formation of p65/ RelA with nuclear Akt1 for enhanced transcriptional activation of NF-kappaB. Biochem Biophys Res Commun 2008; 365:771-776.
35. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104:487-501.
36. Lin-Lee YC, Pham LV, Tamayo AT, et al.. Nuclear localization in the biology of the CD40 receptor in normal and neoplastic human B lymphocytes. J Biol Chem 2006; 281:18878-18887.
37. Zhou HJ, Pham LV, Tamayo AT, et al.. Nuclear CD40 interacts with c-Rel and enhances proliferation in aggressive B-cell lymphoma. Blood 2007; 110:2121-2127.
38. Fu L, Lin-Lee YC, Pham LV, et al.. BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells. Blood 2009; 113:4627-4636.
39. Wright CW, Duckett CS. The aryl hydrocarbon nuclear translocator alters CD30-mediated NF-kappaB-dependent transcription. Science 2009; 323:251-255.
40. Jacque E, Tchenio T, Piton G, Romeo PH, Baud V. RelA repression of RelB activity induces selective gene activation downstream of TNF receptors. Proc Natl Acad Sci USA 2005; 102:14635-14640.
41. Goto A, Matsushita K, Gesellchen V, et al.. Akirins are highly conserved nuclear proteins required for NF-kappaB-dependent gene expression in drosophila and mice. Nat Immunol 2008; 9:97-104.
42. Beutler B, Moresco EM. Akirins versus infection. Nat Immunol 2008; 9:7-9.
43. Gao N, Asamitsu K, Hibi Y, Ueno T, Okamoto T. AKIP1 enhances NF-kappaB-dependent gene expression by promoting the nuclear retention and phosphorylation of p65. J Biol Chem 2008; 283:7834-7843.
44. Kashima L, Toyota M, Mita H, et al.. CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-kappaB. Oncogene 2009; 28:2643-2653.
45. Sarkar D, Park ES, Emdad L, et al.. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 2008; 68:1478-1484.
46. Nozell S, Laver T, Moseley D, et al.. The ING4 tumor suppressor attenuates NF-kappaB activity at the promoters of target genes. Mol Cell Biol 2008; 28:6632-6645.
47. Vanden Berghe W, Ndlovu MN, Hoya-Arias R, et al.. Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochem Pharmacol 2006; 72:1114-1131.
48. Kawahara TL, Michishita E, Adler AS, et al.. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009; 136:62-74.
49. Yeung F, Hoberg JE, Ramsey CS, et al.. Modulation of NFkappaB- dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004; 23:2369-2380.
50. Zwergal A, Quirling M, Saugel B, et al.. C/EBP beta blocks p65 phosphorylation and thereby NF-kappaB-mediated transcription in TNF-tolerant cells. J Immunol 2006; 177:665-672.
51. Saijo K, Winner B, Carson CT, et al.. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 2009; 137:47-59.
52. Bensinger SJ, Tontonoz P. A Nurr1 pathway for neuroprotection. Cell 2009; 137:26-28.
53. Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 2002; 298:1241-1245.
54. Natoli G, Chiocca S. Nuclear ubiquitin ligases, NF-kappaB degradation, and the control of inflammation. Sci Signal 2008; 1:pe1.
55. Chen Y, Li HH, Fu J, et al.. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export. Cell Res 2007; 17:1020-1029.
56. Ashall L, Horton CA, Nelson DE, et al.. Pulsatile stimulation determines timing and specificity of NF-kappaB-dependent transcription. Science 2009; 324:242-246.
57. Saccani S, Marazzi I, Beg AA, Natoli G. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the uclear factor kappaB response. J Exp Med 2004; 200:107-113.
58. Tanaka T, Grusby MJ, Kaisho T. PDLIM2-mediated termination of transcription factor NF-kappaB activation by intranuclear sequestration and degradation of the p65 subunit. Nat Immunol 2007; 8:584-591.
59. + lymphocytes. Nature 2003; 426:853-857.
60. Ryo A, Suizu F, Yoshida Y, et al.. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin- mediated proteolysis of p65/RelA. Mol Cell 2003; 12:1413-1426.
61. Maine GN, Mao X, Komarck CM, Burstein E. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase. EMBO J 2007; 26:436-447.
62. Mao X, Gluck N, Li D, et al.. GCN5 is a required cofactor for a ubiquitin ligase that targets NF-kappaB/RelA. Gene Dev 2009; 23:849-861.
63. Geng H, Wittwer T, Dittrich-Breiholz O, Kracht M, Schmitz ML. Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination. EMBO Rep 2009; 10:381-386.
64. Rodrigues L, Filipe J, Seldon MP, et al.. Termination of NFkappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase. EMBO J 2009; 28:1283-1295.
65. Bartels M, Schweda AT, Dreikhausen U, et al.. Peptide-mediated disruption of NFkappaB/NRF interaction inhibits IL-8 gene activation by IL-1 or Helicobacter pylori. J Immunol 2007; 179:7605-7613.
66. Nourbakhsh M, Kalble S, Dorrie A, et al.. The NF-kappa b repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-kappa b-flanking sequence element. J Biol Chem 2001; 276:4501-4508.
67. Choi KC, Jung MG, Lee YH, et al.. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 2009; 69:583-592.
68. Gilmore TD, Herscovitch M. Inhibitors of NF-kappaB signaling and counting. Oncogene 2006; 25:6887-6899.